Note 9 - Segment Information

9 Months Ended

Mar. 31, 2012

Segment Reporting Disclosure [Text Block]

9.     SEGMENT INFORMATION

The Company has four distinct product lines:  Medication Management systems, Blood and Biologics Management systems, Performance Management systems and Perioperative Management systems.   Based on similar economic characteristics, as well as the nature of products, production processes, customers and distribution methods, the Company has aggregated these product lines into one reporting segment.  Revenue by product line is as follows (in thousands):

	For the Three Months Ended				For the Nine Months Ended
	March 31,				March 31,
	2012		2011		2012		2011
Medication Management Systems:
System sales	$	1,799	$	1,466	$	5,590	$	5,369
Services		5,466		4,615		16,454		13,934
Billing and collections		1,028		990		3,201		3,030
		8,293		7,071		25,245		22,333
Blood and Biologics Management Systems:
System sales		2,981		1,776		6,930		3,958
Services		5,069		4,374		13,856		11,684
		8,050		6,150		20,786		15,642
Performance Management Systems
System sales		256		118		702		267
Services		106		261		726		771
		362		379		1,428		1,038
Perioperative Management Systems
System sales		-		-		-		-
Services		152		174		472		534
		152		174		472		534
Total	$	16,857	$	13,774	$	47,931	$	39,547

Billing and collections revenue is generated from the acquired assets of ARI and to a lesser extent, certain assets of CareCentric.  Revenue from one customer represented approximately 23% and 15% of Mediware’s consolidated revenue for the three and nine months ended March 31, 2012, respectively.

Selected financial information by geographic area is as follows (in thousands):

	For the Three Months Ended March 31,					For the Nine Months Ended March 31,
	2012		2011			2012		2011
Revenue from Unaffiliated Customers:
United States	$	15,122	$	12,469		$	42,928	$	35,063
United Kingdom		1,735		1,305			5,003		4,484
Total	$	16,857	$	13,774		$	47,931	$	39,547
Net Income (Loss):
United States	$	1,762	$	1,472		$	4,809	$	3,901
United Kingdom		94		(69	)		273		289
Total	$	1,856	$	1,403		$	5,082	$	4,190

	As of March 31,
		2012		2011
Identifiable Assets:
United States	$	80,560	$	68,374
United Kingdom		9,753		7,894
Total	$	90,313	$	76,268